Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 54, Issue 5, 2014, Pages 891-898

  Bortoluzzi, Alessandra ^a   Scirè, Carlo Alberto ^b   Bombardieri, Stefano ^c   Caniatti, Luisa ^d   Conti, Fabrizio ^e   De Vita, Salvatore ^f,g   Doria, Andrea ^h   Ferraccioli, Gianfranco ⁱ   Gremese, Elisa ⁱ   Mansutti, Elisa ^f,g   Mathieu, Alessandro ^j   Mosca, Marta ^c   Padovan, Melissa ^a   Piga, Matteo ^j   Tincani, Angela ^k   Tola, Maria Rosaria ^d   Tomietto, Paola ^l   Valesini, Guido ^e   Zen, Margherita ^h   Govoni, Marcello ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b Epidemiology Unit   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d S ANNA HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Azienda Ospedaliero Universitaria 'S Maria della Misericordia'   (Italy)

^g UNIVERSITY OF UDINE   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j UNIVERSITY OF CAGLIARI   (Italy)

^k UNIVERSITY OF BRESCIA   (Italy)

^l University Medical Center 'Ospedali Riuniti' of Trieste   (Italy)

more..

Author keywords

Attribution model; Neuropsychiatric; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; CEREBROVASCULAR DISEASE; CHECKLIST; CLASSIFICATION ALGORITHM; COGNITIVE DEFECT; CONFUSION; CRANIAL NEUROPATHY; DELPHI STUDY; DISEASE DURATION; FEMALE; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONONEUROPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PLEXOPATHY; POLYNEUROPATHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS;

EID: 84929661310     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu384     Document Type: Article

References (28)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
2. Ainiala H, Hietaharju A, Loukkola J et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001;45:419-23.
3. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-500.
4. Hanly JG. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus 2004;13:861-4.
5. Sibbitt WL Jr, Brandt JR, Johnson CR et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-42.
6. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20.
7. Hanly JG, Urowitz MB, O'Keeffe AG et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum 2013; 65:2887-97.
8. Linstone HA, Turoff M. The Delphi Method. Reading, MA, USA: Addison-Wesley, 1975.
9. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-80.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
12. Govoni M, Bombardieri S, Bortoluzzi A et al. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology 2012;51:157-68.
13. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
14. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology 2004;43:1555-60.
15. Tomietto P, D'Agostini S, Annese V, De Vita S, Ferraccioli G. Mycophenolate mofetil and intravenous dexamethasone in the treatment of persistent lupus myelitis. J Rheumatol 2007;34:588-91.
16. Andrade RM, Alarcón GS, González LA et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis 2008;67:829-34.
17. Bertsias GK, Ioannidis JPA, Aringer M et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations:report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010;69:2074-82.
18. Sciascia S, Bertolaccini ML, Baldovino S et al. Central nervous system involvement in systemic lupus erythematosus:overview on classification criteria. Autoimmun Rev 2013;12:426-9.
19. Monov S, Monova D. Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion? Hippokratia 2008;12:103-7.
20. Bertsias G, Ioannidis JPA, Boletis J et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008;67:195-205.
21. Govoni M, Rizzo N, Castellino G, Padovan M, Trotta F. [Neuropsychiatric systemic lupus erythematosus: where are we now?]. Reumatismo 2005;57:215-25.
22. Hanly JG, Urowitz MB, Sanchez-Guerrero J et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265-73.
23. Ruggieri AP. Neuropsychiatric lupus: nomenclature, classification, criteria, and other confusional states. Arthritis Rheum 2001;45:406-9.
24. Nived O, Sturfelt G, Liang MH, De Pablo P. The ACR nomenclature for CNS lupus revisited. Lupus 2003;12:872-6.
25. Hanly JG, McCurdy G, Fougere L, Douglas J-A, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31:2156-62.
26. Hanly JG, Urowitz MB, Su L et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010;69:529-35.
27. Hanly JG, Su L, Farewell V et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009;36:1449-59.
28. Hanly JG. Demystifying neuropsychiatric lupus-is it possible? Bull NYU Hosp Jt Dis 2009;67:276-80.